gene-modified

Type: Keyphrase
Name: gene-modified
First reported Oct 20 2014 - Updated 19 hours ago - 1 reports

Harnessing the Power of Modified T Cells to Treat Cancer

New data from the University of Pennsylvania and The Children’s Hospital of Philadelphia reveal that an immunotherapy, named CTL019, helped 90% of children and adults with acute lymphoblastic leukemia (ALL) who had failed to respond to prior treatments ... [Published PharmTech.com - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth ...

IntroductionIn the field of skin tissue engineering, gelatin-chondroitin-6-sulfate-hyaluronic acid (Gel-C6S-HA) stents are a suitable bio skin substitute. The purpose was to investigate the effect of genetically-modified hair follicle stem cells (HFSCs), ... [Published 7thSpace - Oct 20 2014]
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

Concerns rise as GMO debate shifts from field to dinner table

The Chinese government is trying to convince Zhou Guangxiu that the corn in the congee she wants to feed her son is safe. That may not be easy.Zhou, the owner of a recycling business in the northeast coastal city of Weihai, said one source of her concern ... [Published CHINAdaily.com.cn - Oct 19 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 1 reports

Personalized cellular therapy achieves complete remission in 90 percent of acute lymphoblastic leukemia patients studied

Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019, developed ... [Published Medical Xpress - Oct 15 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

China to Battle GMO Crop Fear From Field to Dinner Table

The Chinese government is trying toconvince Zhou Guangxiu that the corn in the congee she wants tofeed her son is safe. That may not be easy.Zhou, the owner of a recycling business in the northeastcoastal city of Weihai, said one source of her concern ... [Published Bloomberg - Oct 09 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Study Findings from Genethon Broaden Understanding of Interleukin-16 Receptors (A dystrophic muscle broadens the contribution and activation of...

Study Findings from Genethon Broaden Understanding of Interleukin-16 Receptors (A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer)By a News Reporter-Staff News Editor at Gene Therapy Weekly -- ... [Published 4 Traders - Oct 03 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

High-Strength Photoresponsive Hydrogels Enable Surface-Mediated Gene Delivery and Light-Induced Reversible Cell Adhesion/Detachment

In the present study, high-strength photoresponsive hydrogels were prepared by the photoinitiated copolymerization of acrylamide (AAm, hydrophilic hydrogen bonding monomer), 2-vinyl-4,6-diamino-1,3,5-triazine (VDT, hydrophobic hydrogen bonding monomer), ... [Published Langmuir - Sep 22 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Immunotherapy in Pediatric Malignancies

Shusterman S, London WB, Gillies SD et al. Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) Phase II study. J. Clin. Oncol. 28(33), 4969–4975 (2010).Yu AL, Gilman AL, Ozkaynak MF et ... [Published General Medicine eJournal - Sep 19 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Gene Therapy Betters Chemotherapy Tolerance, Effectiveness in Small Glioblastoma Study

By The ASCO PostSeptember 15, 2014, Volume 5, Issue 15Using gene therapy and a combination of chemotherapy drugs, researchers at Fred Hutchinson Cancer Research Center have been able to enhance the tolerance and effectiveness of medications used in treating ... [Published The ASCO Post - Sep 15 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

Neuroscientists Probe CRISPR Transgenics and Treatment Paradigms

CRISPR, a gene-editing technology borrowed from humble bacteria, has taken the biomedical research world by storm. Researchers can use the technique to inactivate genes, add point mutations, or insert entire genes into virtually any spot in the genome ... [Published Alzheimer Research Forum - Sep 13 2014]

Quotes

"China doesn't have a choice when the top suppliers all employ the technology" Zhang said
...results support that CTL019 can produce long-lasting remissions for certain heavily pre-treated ALL patients without further therapy," Frey said. "For our patients who have already relapsed after stem cell transplants, or don't have any options for donors, this option has provided new hope."
According to the news editors, the research concluded: "Therefore, the dystrophic environment diversifies cellular immune response mechanisms induced by gene transfer, with a negative outcome."

More Content

All (10) | News (10) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Harnessing the Power of Modified T Cells to Tre... [Published PharmTech.com - Oct 20 2014]
Gelatin-chondroitin-6-sulfate-hyaluronic acid s... [Published 7thSpace - Oct 20 2014]
Concerns rise as GMO debate shifts from field t... [Published CHINAdaily.com.cn - Oct 19 2014]
Personalized cellular therapy achieves complete... [Published Medical Xpress - Oct 15 2014]
China to Battle GMO Crop Fear From Field to Din... [Published Bloomberg - Oct 09 2014]
Study Findings from Genethon Broaden Understand... [Published 4 Traders - Oct 03 2014]
High-Strength Photoresponsive Hydrogels Enable ... [Published Langmuir - Sep 22 2014]
Immunotherapy in Pediatric Malignancies [Published General Medicine eJournal - Sep 19 2014]
Gene Therapy Betters Chemotherapy Tolerance, Ef... [Published The ASCO Post - Sep 15 2014]
Neuroscientists Probe CRISPR Transgenics and Tr... [Published Alzheimer Research Forum - Sep 13 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.